is the primary energy source for mammalian brain and a continuous supply is vital for normal cerebral function. At rest, the brain is responsible for metabolizing up to 60% of the available circulating glucose, and the efficient transport of glucose across the blood-brain barrier (BRH) and into the various cells that make up the brain is essential. Of the six facilitative glucose transporter proteins that have been cloned [ 11, at least four have been detected in brain: GLUTS 1, 3, 5 and 7. The objective of this report is to describe the location of the various transporters and to provide a quantitative assessment of their relative concentrations.
(;lucose is the primary energy source for mammalian brain and a continuous supply is vital for normal cerebral function. At rest, the brain is responsible for metabolizing up to 60% of the available circulating glucose, and the efficient transport of glucose across the blood-brain barrier (BRH) and into the various cells that make up the brain is essential. Of the six facilitative glucose transporter proteins that have been cloned [ 11, at least four have been detected in brain: GLUTS 1, 3, 5 and 7. The objective of this report is to describe the location of the various transporters and to provide a quantitative assessment of their relative concentrations.
GLLJTl was the first transporter to be detected in brain when antibodies against the human erythrocyte glucose transporter were found to cross-react with the endothelial cells comprising the IjBH [Z] . A broad band of 55 k D a is detected by Western blot analysis of purified cerebral microvessels ( Figure 1 ) [3] . GLUT1 protein is extremely concentrated in these cells and can be readily detected by immunohistochemical techniques [ 4-61, In combination with electron microscopy, such techniques have revealed an asymmetric protein distribution, with more transporters being detected in the abluminal membrane (brain side) than in the luminal membrane (blood side), and the presence of an intracellular pool of transporters (see a review by Partridge and Hoado [7] ). A second isoform of GLUT1 with an apparent molecular mass of 45 kDa, can also be detected in whole brain by Western blotting (Figure 1 ). In terms of relative concentrations, this form appears to be -2-5-fold more concentrated than the 55 k I h form per unit mass brain membrane protein, depending on the region. However, with the exception of the choroid plexus and the occasional astrocyte [8, 9] 'To whom correspondence should be addressed. glial localization for the GLUT1 mRNA by colocalizing the mKNA to cells that express the astrocytic marker glial fibrillary acidic protein (GFAP).
Tissue culture studies have indicated the presence of GLUT1 in both isolated glia and neurons [ 12, 131 . W e are now able to extend this to both oligodendrocytes and microglia (F. Maher, unpublished work) . GLUT 1 has also been detected in Schwann cells in culture [14] . Some caution is necessary when viewing this seemingly universal expression of GLUT1, as enhanced GLIJTl expression has been observed in a variety of proliferating cells when subjected to growth factors, viral transformation and the partial hypoxia associated with tissue culture. Thus, the levels of expression seen in the cultured cells may well be elevated as an artifact of the culture procedures. The converse has also been observed in cultured microvascular endothelial cells which appear to dedifferentiate when placed into culture and exhibit markedly decreased expression of GLIJT1 [ 151.
Although the levels of GLUT1 may vary as a consequence of tissue culture, with the exception of the neurons which will be discussed in more detail below, and perhaps microglia, the other cells express GLUT1 as their only glucose transporter.
GLUT3 mRNA was shown to be distributed throughout the brain, localized to cells with neuronal morphology, although the levels of expression vary considerably from region to region [ 10,161. Until very recently, the immunohistochemical detection of GLUT3 in brain sections, as with the 45 kDa form of GLUT1, appeared to be essentially impossible. However, studies in both rat and human brain have now indicated the presence of GLUT3 in cell membranes that make up cell bodies, dendrites and axons of neurons. Immunoblotting reveals a protein of 4.5-50 kDa and confirms its widespread distribution in neuronal elements including the neurohypophysis, and its absence in white matter, adenohypophysis, pineal gland and cerebral microvessels [20-231. Tissue culture studies with rat cerebellar granule cells were the first to confirm the neuronal distribution of GLUT3 and the progressive increase in expression that occurred with differentiation [24] . The differentiation of the protein appeared to be exclusively at the plasma membranes but was not apparently confined to either axon or dendrites. GLUT5 was first detected in human brain by Western blotting [25] and, based on immunofluorescence data, was subsequently reported to be present in the endothelial cells of the HHH [26] . In conjunction with Llr. Peter Davies and colleagues at the Albert Einstein College of Medicine, our own immunohistochemical analysis has revealed GLUT5 to be present in resident microglial cells in both human and rat brain sections [27] . In addition we have also detected GLUTS in cultured human macrophages which are both functionally and antigenically related to microglia (Figure 1 ). The role of GLIJT5 in small intestine, human testis and sperm appears to be to transport fructose, which is present in fairly high concentrations surrounding these particular cells [28] . This cannot be the case for microglia as the concentration of free fructose is very low in brain, thus suggesting another role for (;I,UT5 in these cells. GILJT7 has been detected in a certain sub-population of astrocytes, as is described in detail by Dr. Ann Hurchell (this issue, To estimate the concentrations of GLUT1 and GLUT3 in the cerebellar granule cell we used the methodology developed by Holman and colleagues to photoaffinity-label the cells with ATB-RMPA photolabel and to sequentially immunoprecipitate the labelled GLUT1 and GLUT3 glucose transporters [31] . From such analysis, the concentrations of both were calculated to be 2-3 pmol/mg and 17-20 pmol/mg for GLUT1 and GLUT3 respectively, giving a total of 19-23 pmol/mg. This is in fairly good agreement with the total number of CRbinding sites in these neurons, -16 pmol/mg. I Jsing these as standards, we have calculated the concentrations of both transporters in whole brain by Western blotting. As mentioned earlier, the ratio of 4.5 kI)a to 55 k h GIAJTI in brain varies between 2:l and 5:1 depending upon the region studied, which corresponds to an average ratio of X.3:3.6 pmollmg for a total of -12pmoVmg. Using a similar analysis a value of 12 pmol/mg is also cal- Although the kinetics of GLUT1 have been extensively studied (see a review by Carruthers I 32 I), there are few definitive data regarding the kinetics of GLIJT3. The most striking difference between the two proteins seems to be that the apparent K,,, for 3-0-methyl glucose is significantly lower for GLUT3 (3.5-10 mM) than for GLUT1 (20 mM) 1.32-343. The difference in K,,, takes on increased significance when the interstitial brain glucose concentration is considered. Estimates based on 2-deoxyglucose and n.m.r. studies suggest that the free brain glucose concentration is of the order of 1-2 mM [35, 36] . This being the case, glial GLUT1 transporters would be operating at 3-5% of their capacity whereas the GI,UT3 transporters present in neurons would be operating at 10-20% efficiency. Thus in the event of a situation where glucose becomes limiting, for example during hypoglycaemia where interstitial glucose falls to < 1 m M , the neurons are better equipped to utilize the available glucose.
The disparity between circulating glucose and interstitial glucose suggests that the limitation is at the level of the WRR. As indicated above, although the highest concentration of glucose transporters occurs at the HHH (60-80 pmol/mg) there are fewer 55 k r h GLUT1 transporters than either 4.5 kDa GLUT1 or GLUT3 transporters in brain, as the microvasculature represents only 2% of the total brain mass. This imbalance is further compounded by the apparent asymmetric distribution within the endothelial cell [7] , in which as little as 30% of the total transporters, i.e. those in the lumenal membrane, are involved in removing the glucose from the blood.
The above discussion has referred to the distribution of transporters in the adult brain. During development there are profound alterations in the proportions of 5 5 D a and 45kDa GIAJTI and GILJT3, as illustrated in Figure 2 . In the newborn rat, cerebral glucose consumption is -20% of that seen in the adult and there are correspondingly low levels of all three transporters, which remain low for the first postnatal week [ 37,381. Subsequently, the microvascular transporter progressively increases over the next weeks and essentially reaches adult levels by day 21. In contrast, there is a delay in the increase in the 45kDa GLIJT1 isoform which appears to coincide with overall brain growth. The 
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Postnatal age (days) increase in GLUT3 is still further delayed and more closely corresponds to the period of synaptogenesis and neuronal maturation. These patterns of expression are entirely consistent with the in situ studies of Bondy et al. [lo] , and it appears that it is the changes in GLUT3 expression which most closely correspond to the changes in cerebral glucose utilization.
Little is known concerning the specific regulation of the expression of any of the brain glucose transporters. The regulation of the BBB 55 kDa GLUTl transporter by hypoglycaemia, and especially hyperglycaemia, is somewhat contentious, as reviewed in depth by Pelligrino et al. [ 391. With regard to GLUT3, we have observed a similar correspondence between GLUT3 expression with neuronal differentiation of cerebellar granule cells [24] as seen in the developmental studies [38] , thus suggesting a relationship between synaptic activity and transporter expression.
Further support for this can now be provided by the observation that the levels of GLUT3 expression in these neuronal cultures can be modulated by agents which depolarize the cells, e.g. high extracellular potassium or N-methyl-u-aspartate, a glutamate receptor agonist [40] . Two physiological situations where an increase in GLUT3 has been induced in the neurohypophysis are streptozotosininduced diabetes and water deprivation [39] . In both cases, there is a rapid increase in the concentration of GLUT3 protein which, in the case of water deprivation, corresponds to an increase in glucose utilization and presumably in both cases reflects the increased vasopressin secretion. Two important pathological situations where transporter expression has recently been shown to be altered are ischaemia and Alzheimer's disease. Lee and Bondy [ l l ] have shown that both GLUT1 and GLUT3 mRNA are increased in rat brain cortex following a focal ischaemic insult. Kalaria and Harik [41] have reported that GLUTl protein is reduced in the brains of patients with Alzheimer's disease. However, recently we have found that there is also a dramatic decrease in GLUT3 protein in regions in which decreased glucose utilization has been detected by positron emission tomography, e.g. parietal and temporal cortex [42, 43] .
Clearly a relationship exists between glucose utilization and glucose transporter expression in the brain. In Figure 3 we have depicted our current thoughts as to which transporters are located in which cells. The next step requires an understanding of which factors regulate their cell-specific expression. Schematic representation of glucose transporter distribution in brain 0 , GLUT3; 0 , GLUT1 55 kDa; . , GLUT1 45 kDa; A , GLUT5.
